These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 34923677)
21. Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancer. Li R; Naidu S; Fan W; Rose K; Huelster H; Grass GD; Vosoughi A; Dhillon J; Kim Y; Gupta S; Jain RK; Zhang J; Zemp L; Yu A; Poch MA; Spiess PE; Pow-Sang J; Gilbert SM; Sexton WJ Urol Oncol; 2023 Nov; 41(11):457.e17-457.e24. PubMed ID: 37880002 [TBL] [Abstract][Full Text] [Related]
22. Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer. Pak JS; Haas CR; Anderson CB; DeCastro GJ; Benson MC; McKiernan JM Urol Oncol; 2021 Nov; 39(11):787.e9-787.e15. PubMed ID: 33865688 [TBL] [Abstract][Full Text] [Related]
23. Long-term oncologic outcomes of robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (ICUD): a multi-center study. Brassetti A; Cacciamani G; Anceschi U; Ferriero M; Tuderti G; Miranda G; Mastroianni R; Desai M; Aron M; Gill I; Gallucci M; Simone G World J Urol; 2020 Apr; 38(4):837-843. PubMed ID: 31190152 [TBL] [Abstract][Full Text] [Related]
24. Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched-pair analysis in a multicenter cohort. Kubota M; Kanno T; Inoue T; Yamasaki T; Okumura K; Ito K; Yamada H; Fujii M; Shimizu Y; Yatsuda J; Moroi S; Shichiri Y; Akao T; Sawada A; Saito R; Kobayashi T; Kawakita M; Ogawa O Int J Urol; 2021 Jun; 28(6):656-664. PubMed ID: 33682243 [TBL] [Abstract][Full Text] [Related]
25. Factors Impacting the Occurrence of Local, Distant and Atypical Recurrences after Robot-Assisted Radical Cystectomy: A Detailed Analysis of 310 Patients. Nguyen DP; Al Hussein Al Awamlh B; O'Malley P; Khan F; Lewicki PJ; Golombos DM; Scherr DS J Urol; 2016 Nov; 196(5):1390-1396. PubMed ID: 27259653 [TBL] [Abstract][Full Text] [Related]
26. Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy. Duivenvoorden WC; Daneshmand S; Canter D; Lotan Y; Black PC; Abdi H; van Rhijn BW; Fransen van de Putte EE; Zareba P; Koskinen I; Kassouf W; Traboulsi SL; Kukreja JE; Boström PJ; Shayegan B; Pinthus JH J Urol; 2016 Dec; 196(6):1627-1633. PubMed ID: 27312316 [TBL] [Abstract][Full Text] [Related]
27. Long-term Oncological Outcomes from an Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL). Khan MS; Omar K; Ahmed K; Gan C; Van Hemelrijck M; Nair R; Thurairaja R; Rimington P; Dasgupta P Eur Urol; 2020 Jan; 77(1):110-118. PubMed ID: 31740072 [TBL] [Abstract][Full Text] [Related]
28. Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer. Chakiryan NH; Jiang DD; Gillis KA; Green E; Hajiran A; Hugar L; Zemp L; Zhang J; Jain R; Chahoud J; Poch M; Manley BJ; Li R; Sexton W; Gilbert SM J Urol; 2021 Oct; 206(4):924-932. PubMed ID: 34032503 [TBL] [Abstract][Full Text] [Related]
29. Early Recurrence Patterns Following Totally Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section (ERUS) Scientific Working Group. Collins JW; Hosseini A; Adding C; Nyberg T; Koupparis A; Rowe E; Perry M; Issa R; Schumacher MC; Wijburg C; Canda AE; Balbay M; Decaestecker K; Schwentner C; Stenzl A; Edeling S; Pokupić S; D'Hondt F; Mottrie A; Wiklund PN Eur Urol; 2017 May; 71(5):723-726. PubMed ID: 27816299 [TBL] [Abstract][Full Text] [Related]
30. Intracorporeal Versus Extracorporeal Neobladder After Robot-assisted Radical Cystectomy: Results From the International Robotic Cystectomy Consortium. Dalimov Z; Iqbal U; Jing Z; Wiklund P; Kaouk J; Kim E; Wijburg C; Wagner AA; Roupret M; Dasgupta P; Gaboardi F; Richstone L; Aboumohamed A; Hussein AA; Guru KA Urology; 2022 Jan; 159():127-132. PubMed ID: 34710397 [TBL] [Abstract][Full Text] [Related]
31. Comparison of 2-Year Oncological Outcome and Early Recurrence Patterns in Patients with Urothelial Bladder Carcinoma Treated with Open or Robot-Assisted Radical Cystectomy with an Extracorporeal Urinary Diversion. Niegisch G; Nini A; Michalski R; Henn A; Mally D; Albers P; Rabenalt R Urol Int; 2018; 101(2):224-231. PubMed ID: 30045033 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Oncologic Outcomes Following Open and Robotic-assisted Radical Cystectomy with both Extracorporeal and Intracorporeal Urinary Diversion. Murthy PB; Lone Z; Munoz Lopez C; Ericson JZK; Thomas L; Caveney M; Gerber D; Khanna A; Abouassaly R; Haber GP; Lee BH Urology; 2021 Aug; 154():184-190. PubMed ID: 33891929 [TBL] [Abstract][Full Text] [Related]
33. Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study. Hinata N; Hussein AA; George S; Trump DL; Levine EG; Omar K; Dasgupta P; Khan MS; Hosseini A; Wiklund P; Guru KA BJU Int; 2017 Apr; 119(4):605-611. PubMed ID: 27743481 [TBL] [Abstract][Full Text] [Related]
34. Pathological downstaging following radical cystectomy for muscle-invasive bladder cancer: Survival outcomes in the setting of neoadjuvant chemotherapy versus transurethral resection only. Cajipe M; Wang H; Elshabrawy A; Kaushik D; Liss M; Svatek R; Wu S; Chowdhury WH; Ramamurthy C; Mansour AM Urol Oncol; 2020 Apr; 38(4):231-239. PubMed ID: 31956078 [TBL] [Abstract][Full Text] [Related]
35. Can anesthetics affect bladder cancer recurrence? Total intravenous versus volatile anesthesia in patients undergoing robot-assisted radical cystectomy: A single institution retrospective analysis. Pfail JL; Katims AB; Gul Z; Rosenzweig SJ; Razdan S; Nathaniel S; Martini A; Mehrazin R; Wiklund PN; Loftus K; Sim A; DeMaria S; Sfakianos JP Urol Oncol; 2021 Apr; 39(4):233.e1-233.e8. PubMed ID: 32951989 [TBL] [Abstract][Full Text] [Related]
37. Analysis of open and intracorporeal robotic assisted radical cystectomy shows no significant difference in recurrence patterns and oncological outcomes. Tan WS; Sridhar A; Ellis G; Lamb B; Goldstraw M; Nathan S; Hines J; Cathcart P; Briggs T; Kelly J Urol Oncol; 2016 Jun; 34(6):257.e1-9. PubMed ID: 26968561 [TBL] [Abstract][Full Text] [Related]
38. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876 [TBL] [Abstract][Full Text] [Related]
39. Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database. Fischer-Valuck BW; Rao YJ; Rudra S; Przybysz D; Germino E; Samson P; Baumann BC; Gay H; Michalski J J Urol; 2018 Feb; 199(2):416-423. PubMed ID: 28842247 [TBL] [Abstract][Full Text] [Related]
40. Comparison of Laparoscopic and Robot-assisted Radical Cystectomy for Bladder Cancer: Perioperative and Oncologic Outcomes. Su S; Gu L; Ma X; Li H; Wang B; Shi T; Zhang X Clin Genitourin Cancer; 2019 Oct; 17(5):e1048-e1053. PubMed ID: 31303560 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]